OncoNano Medicine, Inc. — Form D

OncoNano Medicine, Inc. of Southlake, TX, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-21. The offering totals $60.0M, of which $21.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ravi SrinivasanDirectorSouthlake, TX
Alvaro GuillemExecutive OfficerSouthlake, TX
Jeff KeyserExecutive OfficerSan Carlos, CA
Ravi SrinivasanExecutive OfficerSouthlake, TX
Gina JonesDirectorVancouver, A1
John DyettDirectorSouthlake, TX
John DyettRelated PersonSouthlake, TX
Caleb SmithDirectorSouthlake, TX
Melissa PaoloniExecutive OfficerDallas, TX
Matthew HeadExecutive OfficerSouthlake, TX
Matthew HeadRelated PersonSouthlake, TX
Brett GiroirDirectorCollege Park, GA
Yumin QuiDirectorDallas, TX
Kartik KrishnanDirectorDallas, TX
Kartik KrishnanExecutive OfficerDallas, TX
Joydeep GoswamiDirectorSouthlake, TX
Joydeep GoswamiRelated PersonSouthlake, TX
Ravi SrinivasanRelated PersonSouthlake, TX
Alvaro GuillemDirectorSouthlake, TX
Alvaro GuillemRelated PersonSouthlake, TX
Martin DriscollDirectorSouthlake, TX
Martin DriscollExecutive OfficerSouthlake, TX
Yumin QiuDirectorSouthlake, TX
Paritosh DhawaleDirectorSouthlake, TX
Paritosh DhawaleRelated PersonSouthlake, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2025-06-02D$12.7M$12.7M
2021-11-03D/A$68.4M$68.4M
2021-06-17D/A$60.0M$49.1M
2021-03-26D/A$60.0M$26.4M
2019-04-22D/A$35.4M$33.9M
2018-03-28D$11.7M$11.7M

More